Erratum: Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells (Journal of Clinical Investigation (2006) 116, (3139-3149) doi:10.1172/JCI28184);Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells

Journal of Clinical Investigation

Volumn 116, Issue 12, 2006, Pages 3139-3149

  Ross, Jeffrey J ^a   Hong, Zhigang ^b   Willenbring, Ben ^a   Zeng, Lepeng ^a   Isenberg, Brett ^c   Eu, Han Lee ^a   Reyes, Morayma ^a   Keirstead, Susan A ^a   Weir, E Kenneth ^b   Tranquillo, Robert T ^c   Verfaillie, Catherine M ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL L TYPE; FIBRIN DERIVATIVE; RHO KINASE INHIBITOR; SEROTONIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; MOUSE; MULTIPOTENT STEM CELL; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

EID: 33845322277     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28184C1     Document Type: Erratum

References (50)

1. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
2. Mahoney, W.M., and Schwartz, S.M. 2005. Defining smooth muscle cells and smooth muscle injury. J. Clin. Invest. 115:221-224. doi:10.1172/JCI200524272.
3. Stegemann, J.P., Hong, H., and Nerem, R.M. 2005. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J. Appl. Physiol. 98:2321-2327.
4. Ross, J.J., and Tranquillo, R.T. 2003. ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. Matrix Biol. 22:477-490.
5. Gittenberger-de Groot, A.C., DeRuiter, M.C., Bergwerff, M., and Poelmann, R.E. 1999. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler. Thromb. Vasc. Biol. 19:1589-1594.
6. Sobue, K., Hayashi, K., and Nishida, W. 1999. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol. Cell. Biochem. 190:105-118.
7. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767-801.
8. Van der Loop, F., Schaart, G., Timmer, E., Ramaekers, F., and van Eys, G. 1996. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J. Cell Biol. 134:401-411.
9. Christen, T., et al. 2001. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation. 103:882-888.
10. Jain, M.K., et al. 1996. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J. Biol. Chem. 271:10194-10199.
11. Kumar, M.S., and Owens, G.K. 2003. Combinatorial control of smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol. 23:737-747.
12. Dickson, M.C., et al. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factorbeta 1 knock out mice. Development. 121:1845-1854.
13. Lindahl, P., Johansson, B.R., Leveen, P., and Betsholtz, C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:242-245.
14. Riha, G.M., Lin, P.H., Lumsden, A.B., Yao, Q., and Chen, C. 2005. Roles of hemodynamic forces in vascular cell differentiation. Ann. Biomed. Eng. 33:772-779.
15. Drab, M., et al. 1997. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J. 11:905-915.
16. Sinha, S., Hoofnagle, M.H., Kingston, P.A., McCanna, M.E., and Owens, G.K. 2004. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am. J. Physiol. Cell Physiol. 287:C1560-C1568.
17. Galmiche, M., Koteliansky, V., Briere, J., Herve, P., and Charbord, P. 1993. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 82:66-76.
18. Yoon, Y.S., et al. 2005. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115:326-338. doi:10.1172/JCI200522326.
19. Tsai, R.Y., and McKay, R.D. 2000. Cell contact regulates fate choice by cortical stem cells. J. Neurosci.. 20:3725-3735.
20. Tagliafico, E., et al. 2004. TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J. Cell. Sci. 117:4377-4388.
21. Reyes, M., et al. 2001. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98:2615-2625.
22. Jiang, Y., et al. 2002. Pluripotent nature of adult marrow derived mesenchymal stem cells. Nature. 418:41-49.
23. Jiang, Y., Henderson, D., Blackstad, M., Chen, A., Miller, R.F., and Verfaillie, C.M. 2003. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 100(Suppl 1):11854-11860.
24. Scholer, H.R., Hatzopoulos, A.K., Balling, R., Suzuki, N., and Gruss, P. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8:2543-2550.
25. Breyer, A., Estharabadi, N., Lien, L., and Jiang, Y. 2006. Multipotent adult progenitor cell (MAPC) isolation and culture procedures. Exp. Hematol. In press.
26. Pittenger, M.F., et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science. 284:143-147.
27. Minasi, M.G., et al. 2002. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development. 129:2773-2783.
28. Kogler, G., et al. 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200:123-135.
29. D'Ippolito, G., et al. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell. Sci. 117:2971-2981.
30. Holycross, B.J., Blank, R.S., Thompson, M.M., Peach, M.J., and Owens, G.K. 1992. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ. Res. 71:1525-1532.
31. Blank, R.S., and Owens, G.K. 1990. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J. Cell. Physiol. 142:635-642.
32. Zhang, J.C., et al. 2001. Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol. Cell. Biol. 21:1336-1344.
33. Herring, B.P., Lyons, G.E., Hoggatt, A.M., and Gallagher, P.J. 2001. Telokin expression is restricted to smooth muscle tissues during mouse development. Am. J. Physiol. Cell Physiol. 280:C12-C21.
34. Qian, J., Kumar, A., Szucsik, J.C., and Lessard, J.L. 1996. Tissue and developmental specific expression of murine smooth muscle gamma-actin fusion genes in transgenic mice. Dev. Dyn. 207:135-144.
35. Moosmang, S., Lenhardt, P., Haider, N., Hofmann, F., and Wegener, J.W. 2005. Mouse models to study L-type calcium channel function. Pharmacol. Ther. 106:347-355.
36. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. 2003. A fibrin-based arterial media equivalent. J. Biomed. Mater. Res. A. 66:550-561.
37. Neidert, M.R., Lee, E.S., Oegema, T.R., and Tranquillo, R.T. 2002. Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials. 23:3717-3731.
38. Reusch, P., Wagdy, H., Reusch, R., Wilson, E., and Ives, H.E. 1996. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ. Res. 79:1046-1053.
39. Isenberg, B.C., and Tranquillo, R.T. 2003. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 31:937-949.
40. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. 1996. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
41. Yoshida, T., and Owens, G.K. 2005. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96:280-291.
42. Chang, D.F., et al. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell. 4:107-118.
43. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz, C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047-3055.
44. Dandre, F., and Owens, G.K. 2004. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am. J. Physiol. Heart Circ. Physiol. 286:H2042-H2051.
45. Rodriguez, L.V., et al. 2006. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 103:12167-12172.
46. Sinha, S., et al. 2006. Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells. 24:1678-1688.
47. Zeng, L., et al. 2006. Multi-potent adult progenitor cells from swine bone marrow. Stem Cells. 24:2355-2366.
48. Reyes, M., et al. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109:337-346. doi:10.1172/JCI200214327.
49. Schwartz, R.E., et al. 2002. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. 109:1291-1302. doi:10.1172/JCI200215182.
50. Hong, Z., et al. 2005. Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation. 112:1494-1499.